These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34371133)

  • 1. The mucormycosis epidemic within COVID-19 pandemic- lessons from India.
    Jy Ong J; Cy Chan A; Sharma AK; Sharma S; Sharma VK
    Brain Behav Immun; 2021 Oct; 97():4-5. PubMed ID: 34371133
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic.
    Padma Srivastava MV; Vishnu VY; Pandit AK
    Stroke; 2021 Oct; 52(10):e622-e623. PubMed ID: 34525840
    [No Abstract]   [Full Text] [Related]  

  • 3. An Epidemic of Mucormycosis Coinciding With the COVID-19 Pandemic in India.
    MohanaSundaram A; Thukani Sathanantham S; Kulkarni A; Kulkarni S; Chinchole V; Patil B; Velayutham R
    Asia Pac J Public Health; 2022 Mar; 34(2-3):304-305. PubMed ID: 34779277
    [No Abstract]   [Full Text] [Related]  

  • 4. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Mucormycosis and COVID-19.
    Yadav S
    J Contemp Dent Pract; 2021 Aug; 22(8):855. PubMed ID: 34753834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated mucormycosis: an epidemic within a pandemic.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2021 Oct; 114(6):355-356. PubMed ID: 34109406
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucormycosis: An unanticipated progeny of COVID-19.
    Shrestha GS; Bhandari S; Lamsal R; Gurung U
    JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis.
    Singh R; Kumari A
    ACS Infect Dis; 2021 Aug; 7(8):2211-2213. PubMed ID: 34328718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the second wave of COVID-19 in India.
    Asrani P; Eapen MS; Hassan MI; Sohal SS
    Lancet Respir Med; 2021 Sep; 9(9):e93-e94. PubMed ID: 34216547
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
    Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Black fungus": a perspective on the coronavirus disease 2019 (COVID-19)-associated rhino-orbital mucormycosis epidemic in India.
    Thakar A; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1278-1279. PubMed ID: 34185968
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.
    Islam MR; Rahman MM; Ahasan MT; Sarkar N; Akash S; Islam M; Islam F; Aktar MN; Saeed M; Harun-Or-Rashid M; Hosain MK; Rahaman MS; Afroz S; Bibi S; Rahman MH; Sweilam SH
    Environ Sci Pollut Res Int; 2022 Oct; 29(46):69341-69366. PubMed ID: 35986111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
    Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
    Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucormycosis and COVID-19: Double trouble for India?
    Yasmin F; Najeeb H; Siddiqui SA; Ochani RK
    J Glob Health; 2022; 12():03001. PubMed ID: 35154668
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Mucormycosis in India a Study on Implicated Risk Factors.
    Deepak P; Rao MR; Mandadi K
    J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598140
    [No Abstract]   [Full Text] [Related]  

  • 20. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.